Literature DB >> 113077

Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma.

R D Ryall, T Bates, K A Newton, K Hellmann.   

Abstract

Eight patients with 12 chondrosarcomas were treated with radiation and razoxane (ICRF 159). Two tumors in 1 patient progressed unequivocally, 3 tumors in 3 patients showed no change, and 7 tumors in 5 patients had complete or partial (more than 50%) regressions. At least 2 complete regressions have responded for more than 2 1/2 years at the present time.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 113077     DOI： 10.1002/1097-0142(197909)44:3<891::aid-cncr2820440315>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  4 in total

1.  Mesenchymal chondrosarcoma of the rib: report of a case.

Authors:  T Aoki; M Watanabe; K Takagi; S Tanaka; S Aida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors.

Authors:  C L Vogel; E Gorowski; E Davila; M Eisenberger; J Kosinski; R P Agarwal; N Savaraj
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

3.  The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.

Authors:  Walter Rhomberg
Journal:  Sarcoma       Date:  2006

4.  Combination therapy of a mouse sarcoma using razoxane and electron irradiation.

Authors:  M B Grimshaw; R W Davies; W S Hall
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.